Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
J. Hoes, H. Pasmans, T. M. Schurink-van ’t Klooster, F. R. M. van der Klis, R. Donken, J. Berkhof & H. E. de Melker. (2022) Review of long-term immunogenicity following HPV vaccination: Gaps in current knowledge. Human Vaccines & Immunotherapeutics 18:1.
Read now
Read now
Ralph-Sydney Mboumba Bouassa, Hélène Péré, Mohammad-Ali Jenabian, David Veyer, Jean-François Meye, Antoine Touzé & Laurent Bélec. (2020) Natural and vaccine-induced B cell-derived systemic and mucosal humoral immunity to human papillomavirus. Expert Review of Anti-infective Therapy 18:6, pages 579-607.
Read now
Read now
Indranil Sarkar, Ravendra Garg & Sylvia van Drunen Littel-van den Hurk. (2019) Selection of adjuvants for vaccines targeting specific pathogens. Expert Review of Vaccines 18:5, pages 505-521.
Read now
Read now
Tao Haskins-Coulter, Jo Southern, Nick Andrews & Elizabeth Miller. (2017) Reactogenicity of Cervarix and Gardasil human papillomavirus (HPV) vaccines in a randomized single blind trial in healthy UK adolescent females. Human Vaccines & Immunotherapeutics 13:6, pages 1412-1420.
Read now
Read now
Robine Donken, Johannes A. Bogaards, Fiona R. M. van der Klis, Chris J. L. M. Meijer & Hester E. de Melker. (2016) An exploration of individual- and population-level impact of the 2-dose HPV vaccination schedule in pre-adolescent girls. Human Vaccines & Immunotherapeutics 12:6, pages 1381-1393.
Read now
Read now
Partha Basu, Neerja Bhatla, Twalib Ngoma & Rengaswamy Sankaranarayanan. (2016) Less than 3 doses of the HPV vaccine – Review of efficacy against virological and disease end points. Human Vaccines & Immunotherapeutics 12:6, pages 1394-1402.
Read now
Read now
Articles from other publishers (33)
Andrea Callegaro, Naveen Karkada, Emmanuel Aris & Toufik Zahaf. (2023) Vaccine clinical trials with dynamic borrowing of historical controls: Two retrospective studies. Pharmaceutical Statistics 22:3, pages 475-491.
Crossref
Crossref
Hyun-Woong Cho, Kyung-Jin Min, Sang-Hoon Kwon, Kidong Kim, Sunghoon Kim, Seok Ju Seong, Yong Jung Song, Keun Ho Lee, Shin-Wha Lee, Jeong-Won Lee, Woong Ju, Young Tae Kim & Jae Kwan Lee. (2021) Updated clinical guideline for human papillomavirus vaccine: the Korean Society of Gynecologic Oncology guidelines. Journal of Gynecologic Oncology 32:6.
Crossref
Crossref
Andrew M. Secor, Matthew Driver, Brenda Kharono, Dianna Hergott, Gui Liu, Ruanne V. Barnabas, Peter Dull, Stephen E. Hawes & Paul K. Drain. (2020) Immunogenicity of Alternative Dosing Schedules for HPV Vaccines among Adolescent Girls and Young Women: A Systematic Review and Meta-Analysis. Vaccines 8:4, pages 618.
Crossref
Crossref
Yi-Qi Wang, Hélène Bazin-Lee, Jay T. Evans, Carolyn R. Casella & Thomas C. Mitchell. (2020) MPL Adjuvant Contains Competitive Antagonists of Human TLR4. Frontiers in Immunology 11.
Crossref
Crossref
Qi Chen, Hui Zhao, Xingmei Yao, Zhijie Lin, Juan Li, Bizhen Lin, Rui Wang, Yue Huang, Yingying Su, Ting Wu, Changgui Li, Huirong Pan, Shoujie Huang, Jun Zhang & Ningshao Xia. (2020) Comparing immunogenicity of the Escherichia coli-produced bivalent human papillomavirus vaccine in females of different ages. Vaccine 38:39, pages 6096-6102.
Crossref
Crossref
Andrea Ciavattini, Luca Giannella, Rosa De Vincenzo, Jacopo Di Giuseppe, Maria Papiccio, Ankica Lukic, Giovanni Delli Carpini, Antonio Perino, Antonio Frega, Francesco Sopracordevole, Maggiorino Barbero & Murat Gultekin. (2020) HPV Vaccination: The Position Paper of the Italian Society of Colposcopy and Cervico-Vaginal Pathology (SICPCV). Vaccines 8:3, pages 354.
Crossref
Crossref
Sara E. Landers, Jenny K. R. Francis, Marilyn C. Morris, Christine Mauro & Susan L. Rosenthal. (2020) Adolescent and Parent Perceptions about Participation in Biomedical Sexual Health Trials. Ethics & Human Research 42:3, pages 2-11.
Crossref
Crossref
Hanna Bergman, Brian S Buckley, Gemma Villanueva, Jennifer Petkovic, Chantelle Garritty, Vittoria Lutje, Alina Ximena Riveros-Balta, Nicola Low & Nicholas Henschke. (2019) Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. Cochrane Database of Systematic Reviews 2019:11.
Crossref
Crossref
C. Raina MacIntyre, Peter J. Shaw, Fiona E. Mackie, Christina Boros, Helen Marshall, Holly Seale, Sean E. Kennedy, Aye Moa, Abrar Ahmad Chughtai, Mallory Trent, Edward V O'Loughlin & Michael Stormon. (2019) Long term follow up of persistence of immunity following quadrivalent Human Papillomavirus (HPV) vaccine in immunocompromised children. Vaccine 37:37, pages 5630-5636.
Crossref
Crossref
Jihui Lee, Shreedevi Arun Kumar, Yong Yu Jhan & Corey J. Bishop. (2018) Engineering DNA vaccines against infectious diseases. Acta Biomaterialia 80, pages 31-47.
Crossref
Crossref
Lauri E. Markowitz, Melanie Drolet, Norma Perez, Mark Jit & Marc Brisson. (2018) Human papillomavirus vaccine effectiveness by number of doses: Systematic review of data from national immunization programs. Vaccine 36:32, pages 4806-4815.
Crossref
Crossref
Ligia A. Pinto, Joakim Dillner, Simon Beddows & Elizabeth R. Unger. (2018) Immunogenicity of HPV prophylactic vaccines: Serology assays and their use in HPV vaccine evaluation and development. Vaccine 36:32, pages 4792-4799.
Crossref
Crossref
Marc Arbyn, Lan Xu, Cindy Simoens & Pierre PL Martin-Hirsch. (2018) Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane Database of Systematic Reviews 2020:3.
Crossref
Crossref
Lan Lin, Mercedes Macias Parra, Victor Y. Sierra, Albino Salas Cespedes, Maria Angelica Granados, Adriana Luque, Silvia Damaso, Maria Mercedes Castrejon Alba, Luis Romano-Mazzotti & Frank Struyf. (2018) Safety and Immunogenicity of the HPV-16/18 AS04-adjuvanted Vaccine in 4–6-year-old Girls. Pediatric Infectious Disease Journal 37:4, pages e93-e102.
Crossref
Crossref
Richard B. S. Roden & Peter L. Stern. (2018) Opportunities and challenges for human papillomavirus vaccination in cancer. Nature Reviews Cancer 18:4, pages 240-254.
Crossref
Crossref
Anastasia Phillips, Cyra Patel, Alexis Pillsbury, Julia Brotherton & Kristine Macartney. (2017) Safety of Human Papillomavirus Vaccines: An Updated Review. Drug Safety 41:4, pages 329-346.
Crossref
Crossref
Maria Ganczak, Barbara Owsianka & Marcin Korzeń. (2018) Factors that Predict Parental Willingness to Have Their Children Vaccinated against HPV in a Country with Low HPV Vaccination Coverage. International Journal of Environmental Research and Public Health 15:4, pages 645.
Crossref
Crossref
Ehsan Saburi & Asma Behdari. (2018) Successful treatment of common warts with alum. Ancient Science of Life 37:4, pages 214.
Crossref
Crossref
Ting Fan Leung, Anthony Pak-Yin Liu, Fong Seng Lim, Franck Thollot, Helen May Lin Oh, Bee Wah Lee, Lars Rombo, Ngiap Chuan Tan, Roman Rouzier, Stéphanie De Simoni, Pemmaraju Suryakiran, Marjan Hezareh, Florence Thomas, Nicolas Folschweiller & Frank Struyf. (2018) Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9–14 years: Results to month 36 from a randomized trial. Vaccine 36:1, pages 98-106.
Crossref
Crossref
Jennifer Cunningham Erves, Tilicia L. Mayo-Gamble, Pamela C. Hull, Lauren Duke & Stephania T. Miller. (2017) Adolescent Participation in HPV Vaccine Clinical Trials: Are Parents Willing?. Journal of Community Health 42:5, pages 894-901.
Crossref
Crossref
Thomas C Mitchell & Carolyn R Casella. (2017) No pain no gain? Adjuvant effects of alum and monophosphoryl lipid A in pertussis and HPV vaccines. Current Opinion in Immunology 47, pages 17-25.
Crossref
Crossref
Diane M. Harper & Leslie R. DeMars. (2017) HPV vaccines – A review of the first decade. Gynecologic Oncology 146:1, pages 196-204.
Crossref
Crossref
Aubrey N. Jones, Jenna W. Bartlett, Rebecca A. Bates & Tsz-Yin So. (2017) Primary Immunization of Human Papillomavirus Vaccine in the Pediatric Population: What Is the Verdict Now?. Clinical Pediatrics 56:7, pages 605-615.
Crossref
Crossref
Li-Min HuangThanyawee PuthanakitChiu Cheng-Hsun, Tang Ren-BinTino SchwarzAngelo PellegrinoSusanna EspositoLouise FrenetteShelly McNeilPaolo Durando, Paul Rheault, Carlo GiaquintoMichael HornKarl Ulrich PetryKlaus Peters, Toma AzharPeter HillemannsStephanie De Simoni, Damien Friel, Suryakiran Pemmaraju, Marjan Hezareh, Florence Thomas, Dominique Descamps, Nicolas Folschweiller & Frank Struyf. (2017) Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9–14 Years: A Randomized Trial. The Journal of Infectious Diseases 215:11, pages 1711-1719.
Crossref
Crossref
Jacqueline M. Hirth, Mihyun Chang, Vicente A. Resto, Fangjian Guo & Abbey B. Berenson. (2017) Prevalence of oral human papillomavirus by vaccination status among young adults (18–30 years old). Vaccine 35:27, pages 3446-3451.
Crossref
Crossref
Fei Yin, Yajun Wang, Na Chen, Dunquan Jiang, Yefeng Qiu, Yan Wang, Mei Yan, Jianping Chen, Haijiang Zhang & Yongjiang Liu. (2017) A novel trivalent HPV 16/18/58 vaccine with anti-HPV 16 and 18 neutralizing antibody responses comparable to those induced by the Gardasil quadrivalent vaccine in rhesus macaque model. Papillomavirus Research 3, pages 85-90.
Crossref
Crossref
Behnam Toghani Pour, Seyed Masoud Hosseini & Mohammad Taghi Kardi. (2017) Frequency of Human Papilloma Virus Genotypes in Patient Samples From Isfahan (Iran) Using Polymerase Chain Reaction Reverse Dot Blot Method. Jundishapur Journal of Microbiology In Press:In Press.
Crossref
Crossref
R. Toy & K. Roy. 2017. Comprehensive Biomaterials II. Comprehensive Biomaterials II
445
463
.
Thanyawee Puthanakit, Li-Min Huang, Cheng-Hsun Chiu, Ren-Bin Tang, Tino F. Schwarz, Susanna Esposito, Louise Frenette, Carlo Giaquinto, Shelly McNeil, Paul Rheault, Paolo Durando, Michael Horn, Maximilian Klar, Sylviane Poncelet, Stéphanie De Simoni, Damien Friel, Benoit De Muynck, Pemmaraju V. Suryakiran, Marjan Hezareh, Dominique Descamps, Florence Thomas & Frank Struyf. (2016) Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9–14 Years Versus a 3-Dose Regimen in Women Aged 15–25 Years. Journal of Infectious Diseases 214:4, pages 525-536.
Crossref
Crossref
Ciro Comparetto. (2016) Immunogenicity of One-Dose Quadrivalent Human Papillomavirus Vaccine in Girls. Women's Health 2:2.
Crossref
Crossref
Kyung-Jin Min, Sang-Hoon Kwon, Sunghoon Kim, Hyun Jung KimSeok Ju SeongYong Jung Song, Jin Woo ShinKeun-Ho Lee, Myong Cheol Lim, Hyun Hoon Chung, Woong JuJin Hwa HongJeong-Won Lee, Jae-Weon Kim, Duk-Soo BaeJae-Kwan Lee. (2016) Preventive vaccination against cervical cancer: Korean Society of Gynecologic Oncology Guideline. Journal of Gynecologic Oncology 27:3.
Crossref
Crossref
Matti Lehtinen & Dan Apter. (2015) Gender-neutrality, herd effect and resilient immune response for sustainable impact of HPV vaccination. Current Opinion in Obstetrics & Gynecology 27:5, pages 326-332.
Crossref
Crossref
Donatella Panatto, Daniela Amicizia, Nicola Luigi Bragazzi, Emanuela Rizzitelli, Daniela Tramalloni, Ivana Valle & Roberto Gasparini. 2015.
231
322
.